These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7658314)

  • 1. Comparison of high dose therapy of rhEPO, given two or three times a week in premature infants.
    Bock W; Gröhs B; Minihold B; Schemper M; Lischka A
    J Perinat Med; 1995; 23(1-2):133-8. PubMed ID: 7658314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
    Meyer MP; Haworth C; Meyer JH; Commerford A
    J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group.
    Maier RF; Obladen M; Kattner E; Natzschka J; Messer J; Regazzoni BM; Speer CP; Fellman V; Grauel EL; Groneck P; Wagner M; Moriette G; Salle BL; Verellen G; Scigalla P
    J Pediatr; 1998 May; 132(5):866-70. PubMed ID: 9602202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effect of different dosage of recombinant human erythropoietin on anemia of premature infants.
    Chang L; Liu W; Liao C; Zhao X
    J Tongji Med Univ; 1998; 18(4):239-42. PubMed ID: 10806855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 iron doses in infants receiving recombinant human erythropoietin therapy.
    Nazir S; Peverini RL; Deming DD; Hopper AO; Vyhmeister NR
    Arch Pediatr Adolesc Med; 2002 Jun; 156(6):540-4. PubMed ID: 12038884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants.
    Klipp M; Holzwarth AU; Poeschl JM; Nelle M; Linderkamp O
    Acta Paediatr; 2007 Feb; 96(2):253-6. PubMed ID: 17429915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.
    Donato H; Vain N; Rendo P; Vivas N; Prudent L; Larguía M; Digregorio J; Vecchiarelli C; Valverde R; García C; Subotovsky P; Solana C; Gorenstein A
    Pediatrics; 2000 May; 105(5):1066-72. PubMed ID: 10790464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin in autologous blood donors: a dose-finding study.
    Biesma DH; Kraaijenhagen RJ; Dalmulder J; Marx JJ; Van De Wiel A
    Br J Haematol; 1994 Jan; 86(1):30-5. PubMed ID: 8011544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.
    Carnielli V; Montini G; Da Riol R; Dall'Amico R; Cantarutti F
    J Pediatr; 1992 Jul; 121(1):98-102. PubMed ID: 1625101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
    Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
    J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human erythropoietin in infants with very low birth weights.
    Samanci N; Ovali F; Dagoglu
    J Int Med Res; 1996; 24(2):190-8. PubMed ID: 8737229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial.
    Brown MS; Keith JF
    Pediatrics; 1999 Aug; 104(2 Pt 1):210-5. PubMed ID: 10428996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily subcutaneous administration of recombinant human erythropoietin (rhEPO) in peritoneal dialysis patients: a European dose-response study.
    Faller B; Slingeneyer A; Waller M; Michel C; Grützmacher P; Müller HP; Barany P; Grabensee B; Issad B; Schmitt H
    Clin Nephrol; 1993 Sep; 40(3):168-75. PubMed ID: 8403573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery.
    Sowade O; Messinger D; Franke W; Sowade B; Scigalla P; Warnke H
    Eur J Haematol; 1998 Apr; 60(4):252-9. PubMed ID: 9579879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.